4D Molecular Therapeutics, a Phase 1/2 gene therapy biotech developing novel AAVs for ophthalmic diseases, raised $193 million by offering 8.4 million shares at $23, the high end of the upwardly revised range of $22 to $23. The company offered 1.4 million more shares than anticip
CBRE Acquisition Holdings, a blank check company formed by real estate giant CBRE targeting growth companies, raised $350 million by offering 35 million units at $10. The offered units consist of one share of common stock and one quarter warrant, exercisable at $11.00. The c
Certara, which provides biosimulation software and services used for drug development, raised $668 million by offering 29.1 million shares (50% primary) at $23, above the range of $19 to $22.
The company originally filed to offer 24.4 million shares (58% primary), but selling s
Nanobiotix, a late-stage French developer of nanoparticle drugs that improve cancer radiotherapy, raised $99 million by offering 7.3 million ADS equivalents at $13.50, the low end of the range of $13.50 to $14.50. The company offered 0.8 million more ADS equivalents than anticipa
The IPO market remained super solid this year. Though Renaissance IPO ETF IPO lost 3.1% on Dec 9 on broader market concerns, the prospect looks pretty upbeat. There have been 205 IPOs priced this year, up 34.9% from last year, per renaissancecapital. Total proceeds raised are $74
AbCellera Biologics, which provides an AI powered drug discovery platform for antibody therapies, raised the proposed deal size for its upcoming IPO on Thursday.
The Vancouver, Canada-based company now plans to raise $403 million by offering 23 million shares at a price range of
4D Molecular Therapeutics, a Phase 1/2 gene therapy biotech developing novel AAVs for ophthalmic diseases, raised the proposed deal size for its upcoming IPO on Thursday.
The Emeryville, CA-based company now plans to raise $158 million by offering 7 million shares at a price ran
Airbnb, which provides a platform for booking short-term stays from a global network of locals, raised $3.5 billion by offering 51.3 million shares (97% primary) at $68, well above the upwardly revised range of $56 to $60.
The company initially planned to offer its shares
Airbnb, which provides a platform for booking short-term stays from a global network of locals, raised $3.5 billion by offering 51.3 million shares (97% primary) at $68, well above the upwardly revised range of $56 to $60. The company originally planned to offer its shares at a r
Periphas Capital Partnering Corp., a blank check company formed by Periphas Capital, raised $360 million by offering 14.4 million units at $25. The SPAC raised 20% more capital than anticipated. The offered units consist of one share of common stock and quarter-warrants, exercisa
RMG Acquisition II, the second blank check company formed by Riverside's James Carpenter and former Carlyle executive Robert Mancini, raised $300 million by offering 30 million units at $10. The company offered 5 million more units than anticipated, though it had previously downs
RMG Acquisition II, the second blank check company formed by Riverside's James Carpenter and former Carlyle executive Robert Mancini, raised $300 million by offering 30 million units at $10. The company offered 5 million more units than anticipated, though it had previously downs
Muliang Viagoo Technology, a Chinese manufacturer and distributor of organic fertilizer and agricultural products, announced terms for its IPO on Wednesday. The company originally filed in December 2019 under the name Muliang Agritech.
The Shanghai, China-based company plans to
Carney Technology Acquisition II, a blank check company led by the former CEO of Brocade Communications targeting the technology industry, raised $350 million by offering 35 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisa
Hydrofarm Holdings Group, which sells hydroponics and specialty indoor gardening supplies, raised $173 million by offering 8.7 million shares at $20, above the upwardly revised range of $17 to $18. The company originally planned to offer 8.7 million shares at a range of $14 to $1
Nanobiotix, a late-stage French developer of nanoparticle drugs that improve cancer radiotherapy, set the range for its upcoming IPO on Wednesday.
The Paris, France-based company now plans to raise $91 million by offering 6.5 million shares at a price range of $13.50 to $14.50.
Infobird, which provides a SaaS customer engagement platform in China, filed on Wednesday with the SEC to raise up to $25 million in an initial public offering.
The Beijing, China-based company plans to raise $25 million by offering 6.3 million shares at $4. At the proposed pric
BioAtla, a Phase 2 biotech developing antibody therapies for solid tumor cancers, announced terms for its IPO on Wednesday.
The San Diego, CA-based company plans to raise $150 million by offering 9.4 million shares at a price range of $15 to $17. At the midpoint of the proposed
Renaissance Capital
Checked
18 minutes 32 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs